MIRANDA OAKELEY: Open Payments
NPI 1225711799 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 44 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $921 · 2025 $805
Food & beverage: $805
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $341 |
| UCB, Inc. | 4 | $118 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| SOBI, INC | 1 | $47 |
| Janssen Biotech, Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Lilly USA, LLC | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Amgen Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: SKYRIZI, RINVOQ, Bimzelx, BENLYSTA, TREMFYA, SAPHNELO, TALTZ, COSENTYX.
Industry payments across NM — which companies pay providers there.
